_____________________________________________________________________________________________ Abingdon
Health
service to its clients.“ When a customer aims to develop a clinical product, they must submit two key components of their technical file. The first is analytical performance, which includes laboratory testing for sensitivity, specificity, and shelf life, as well as transport studies. Clinical trials are the second component, where real-world usage of the product is evaluated in the field. Our investment in the analytical laboratory allows us to offer a comprehensive service, part of which includes collaborating with customers in building their technical files. Moreover, we can manage their clinical trials while performing all necessary analytical testing within our own laboratory. We felt there was a significant opportunity in this area, as many existing testing laboratories primarily focus on therapeutics, whereas we are a dedicated IVD and MedTech laboratory. This focus not only supports the rest of the business but also allows us to provide our services on a standalone basis. Our laboratory has been up
and running for the best part of six months and is very busy. We are planning to invest in and expand our laboratory service to make it available at our US facility in Madison, Wisconsin shortly. Establishing this analytical laboratory services in the US is a key part of our expansion plans, as it facilitates the transfer of clinical samples within the territory without dealing with the logistical challenges of shipping across the Atlantic,” Chris ends.
Abingdon’ s investments in the US and in the establishment of its analytical performance lab reflect its commitment to innovation and comprehensive service. By integrating cutting-edge analytical capabilities, a flexible manufacturing approach and a global footprint, the company is well-positioned to capitalize on emerging opportunities in the field of in-vitro diagnostic solutions and beyond. ■
www. abingdonhealth. com
manufacturing-today. com 173